| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
* Department of Medical Microbiology, Leiden University Medical Center, Leiden, The Netherlands; and Section of Infection and Immunity, Cardiff University, Wales College of Medicine, Cardiff, United Kingdom
Human herpesviruses, including EBV, persist for life in infected individuals. During the lytic replicative cycle that is required for the production of infectious virus and transmission to another host, many viral Ags are expressed. Especially at this stage, immune evasion strategies are likely to be advantageous to avoid elimination of virus-producing cells. However, little is known about immune escape during productive EBV infection because no fully permissive infection model is available. In this study, we have developed a novel strategy to isolate populations of cells in an EBV lytic cycle based on the expression of a reporter gene under the control of an EBV early lytic cycle promoter. Thus, induction of the viral lytic cycle in transfected EBV+ B lymphoma cells resulted in concomitant reporter expression, allowing us, for the first time, to isolate highly purified cell populations in lytic cycle for biochemical and functional studies. Compared with latently infected B cells, cells supporting EBV lytic cycle displayed down-regulation of surface HLA class I, class II, and CD20, whereas expression levels of other surface markers remained unaffected. Moreover, during lytic cycle peptide transport into the endoplasmic reticulum, was reduced to <30% of levels found in latent infection. Because steady-state levels of TAP proteins were unaffected, these results point toward EBV-induced interference with TAP function as a specific mechanism contributing to the reduced levels of cell surface HLA class I. Our data implicate that EBV lytic cycle genes encode functions to evade T cell recognition, thereby creating a window for the generation of viral progeny.
This article has been cited by other articles:
|
|
 |
|
  M. J. Bell, R. J. M. Abbott, N. P. Croft, A. D. Hislop, and S. R. Burrows An HLA-A2-Restricted T-Cell Epitope Mapped to the BNLF2a Immune Evasion Protein of Epstein-Barr Virus That Inhibits TAP J. Virol., March 15, 2009; 83(6): 2783 - 2788. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. Brooks, S. P. Lee, A. M. Leese, W. A. Thomas, M. Rowe, and A. B. Rickinson Cyclical Expression of EBV Latent Membrane Protein 1 in EBV-Transformed B Cells Underpins Heterogeneity of Epitope Presentation and CD8+ T Cell Recognition J. Immunol., February 15, 2009; 182(4): 1919 - 1928. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Horst, D. van Leeuwen, N. P. Croft, M. A. Garstka, A. D. Hislop, E. Kremmer, A. B. Rickinson, E. J. H. J. Wiertz, and M. E. Ressing Specific Targeting of the EBV Lytic Phase Protein BNLF2a to the Transporter Associated with Antigen Processing Results in Impairment of HLA Class I-Restricted Antigen Presentation J. Immunol., February 15, 2009; 182(4): 2313 - 2324. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Roder, L. Geironson, I. Bressendorff, and K. Paulsson Viral Proteins Interfering with Antigen Presentation Target the Major Histocompatibility Complex Class I Peptide-Loading Complex J. Virol., September 1, 2008; 82(17): 8246 - 8252. [Full Text] [PDF]
|
|
|
|
|
|
G. E. Dugan and E. W. Hewitt Structural and Functional Dissection of the Human Cytomegalovirus Immune Evasion Protein US6 J. Virol., April 1, 2008; 82(7): 3271 - 3282. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Zuo, W. Thomas, D. van Leeuwen, J. M. Middeldorp, E. J. H. J. Wiertz, M. E. Ressing, and M. Rowe The DNase of Gammaherpesviruses Impairs Recognition by Virus-Specific CD8+ T Cells through an Additional Host Shutoff Function J. Virol., March 1, 2008; 82(5): 2385 - 2393. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. D. Hislop, M. E. Ressing, D. van Leeuwen, V. A. Pudney, D. Horst, D. Koppers-Lalic, N. P. Croft, J. J. Neefjes, A. B. Rickinson, and E. J.H.J. Wiertz A CD8+ T cell immune evasion protein specific to Epstein-Barr virus and its close relatives in Old World primates J. Exp. Med., August 6, 2007; 204(8): 1863 - 1873. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. J. Wiertz, R. Devlin, H. L. Collins, and M. E. Ressing Herpesvirus Interference with Major Histocompatibility Complex Class II-Restricted T-Cell Activation J. Virol., May 1, 2007; 81(9): 4389 - 4396. [Full Text] [PDF]
|
|
|
|
 |
|
 M. Rowe, B. Glaunsinger, D. van Leeuwen, J. Zuo, D. Sweetman, D. Ganem, J. Middeldorp, E. J. H. J. Wiertz, and M. E. Ressing Host shutoff during productive Epstein-Barr virus infection is mediated by BGLF5 and may contribute to immune evasion PNAS, February 27, 2007; 104(9): 3366 - 3371. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. O. Guerreiro-Cacais, M. Uzunel, J. Levitskaya, and V. Levitsky Inhibition of Heavy Chain and {beta}2-Microglobulin Synthesis as a Mechanism of Major Histocompatibility Complex Class I Downregulation during Epstein-Barr Virus Replication J. Virol., February 1, 2007; 81(3): 1390 - 1400. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Y. Pappworth, E. C. Wang, and M. Rowe The Switch from Latent to Productive Infection in Epstein-Barr Virus-Infected B Cells Is Associated with Sensitization to NK Cell Killing J. Virol., January 15, 2007; 81(2): 474 - 482. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. D. Lipinska, D. Koppers-Lalic, M. Rychlowski, P. Admiraal, F. A. M. Rijsewijk, K. Bienkowska-Szewczyk, and E. J. H. J. Wiertz Bovine Herpesvirus 1 UL49.5 Protein Inhibits the Transporter Associated with Antigen Processing despite Complex Formation with Glycoprotein M. J. Virol., June 1, 2006; 80(12): 5822 - 5832. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
